View in EDS PDF Full Text

Knowledge, attitudes, and barriers toward deep brain stimulation for Parkinson’s disease in Mexico.

Saved in:
Bibliographic Details
Title: Knowledge, attitudes, and barriers toward deep brain stimulation for Parkinson’s disease in Mexico.
Alternate Title: Conocimiento, actitudes y barreras hacia la estimulación cerebral profunda para Parkinson en México.
Authors: Martínez-Ramírez, Daniel1 daniel.martinez-ramirez@tec.mx, Diaz-Martinez, Armando2, Dávila-García, Mirna E.1, Tapia-Rodríguez, Daniel F.1, Amezcua-Gómez, Pedro A.1, Sánchez-Ramírez, Karen I.3, González-González, Mirna1
Source: Revista Mexicana de Neurociencia. Jul/Aug2025, Vol. 26 Issue 4, p113-119. 7p.
Subjects: PARKINSON'S disease, DEEP brain stimulation, PHYSICIANS, AWARENESS, SOCIOLOGY, HEALTH services accessibility, ATTITUDE (Psychology)
Geographic Terms: MEXICO
Abstract (English): Objective: Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder among individuals over 50 years old and poses a significant public health challenge in Mexico. While deep brain stimulation (DBS) is an effective therapy for improving motor symptoms and reducing medication dependency, its adoption in Mexico faces multiple barriers. This study aimed to evaluate the knowledge, attitudes, and perceived barriers among physicians regarding DBS to identify key areas for optimizing its accessibility for PD patients. Methods: A descriptive qualitative study was conducted using a 19-question online survey targeting Mexican physicians who treat patients with PD. A total of 69 physicians from various specialties participated. Data were analyzed using descriptive statistics and thematic analysis. Results: Among respondents, 89.9% considered DBS to be safe, and 94.2% did not perceive it as a last resort treatment. However, 71.0% lacked specialized training in DBS, and 34.8% had no contact with specialized DBS centers. The main reported barriers included the high cost of the procedure (79.7%), centralization of services in major cities (29%), and limited knowledge among physicians and patients (21.7%). Conclusions: Despite favorable attitudes toward DBS in Mexico, economic, educational, and infrastructural barriers hinder its implementation. It is crucial to develop funding policies, decentralize services, and strengthen medical training to ensure equitable and timely access to this advanced therapy. [ABSTRACT FROM AUTHOR]
Abstract (Spanish): Objetivo: La enfermedad de Parkinson (EP) es el segundo trastorno neurodegenerativo más prevalente en mayores de 50 años y representa un desafío significativo para la salud pública en México. Aunque la estimulación cerebral profunda (ECP) es una terapia eficaz para mejorar los síntomas motores y reducir la dependencia de medicamentos, su adopción en México enfrenta múltiples barreras. Este estudio tuvo como objetivo evaluar el conocimiento, las actitudes y las barreras percibidas entre los médicos respecto a la ECP para identificar áreas clave que optimicen su accesibilidad para los pacientes con EP. Métodos: Se realizó un estudio descriptivo cualitativo mediante una encuesta en línea de 19 preguntas dirigida a médicos mexicanos que atienden pacientes con EP. Participaron 69 médicos de diversas especialidades. Los datos fueron analizados utilizando estadísticas descriptivas y análisis temático. Resultados: El 89.9% de los encuestados consideró que la ECP es segura, y el 94.2% no la percibe como una terapia de última línea. Sin embargo, el 71.0% carecía de capacitación especializada en ECP, y el 34.8% no tenía contacto con centros especializados. Las principales barreras reportadas incluyeron el alto costo del procedimiento (79.7%), la centralización de los servicios en ciudades principales (29%) y el conocimiento limitado entre médicos y pacientes (21.7%). Conclusiones: A pesar de las actitudes favorables hacia la ECP en México, las barreras económicas, educativas y de infraestructura dificultan su implementación. Es fundamental desarrollar políticas de financiamiento, descentralizar servicios y fortalecer la capacitación médica para garantizar un acceso equitativo y oportuno a esta terapia avanzada. [ABSTRACT FROM AUTHOR]
Copyright of Revista Mexicana de Neurociencia is the property of Academia Mexicana de Neurologia and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: MedicLatina
Description
Abstract:Objective: Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder among individuals over 50 years old and poses a significant public health challenge in Mexico. While deep brain stimulation (DBS) is an effective therapy for improving motor symptoms and reducing medication dependency, its adoption in Mexico faces multiple barriers. This study aimed to evaluate the knowledge, attitudes, and perceived barriers among physicians regarding DBS to identify key areas for optimizing its accessibility for PD patients. Methods: A descriptive qualitative study was conducted using a 19-question online survey targeting Mexican physicians who treat patients with PD. A total of 69 physicians from various specialties participated. Data were analyzed using descriptive statistics and thematic analysis. Results: Among respondents, 89.9% considered DBS to be safe, and 94.2% did not perceive it as a last resort treatment. However, 71.0% lacked specialized training in DBS, and 34.8% had no contact with specialized DBS centers. The main reported barriers included the high cost of the procedure (79.7%), centralization of services in major cities (29%), and limited knowledge among physicians and patients (21.7%). Conclusions: Despite favorable attitudes toward DBS in Mexico, economic, educational, and infrastructural barriers hinder its implementation. It is crucial to develop funding policies, decentralize services, and strengthen medical training to ensure equitable and timely access to this advanced therapy. [ABSTRACT FROM AUTHOR]
ISSN:16655044
DOI:10.24875/RMN.24000069